Background Section 1833(t)(17) of the Act, which applies to subsection (d) hospitals (as defined under section 1886(d)(1)(B) of the Act), states that hospitals that fail to report data required to be submitted on measures selected by the Secretary, in the form and manner, and at a time, specified by the Secretary will incur a 2.0-percentage point reduction to their OPD fee schedule increase factor
The effective date of this proposed policy would be January 1, 2026
The 20mg vial at 8mg per week provides 2.5 weekly doses, covering about two and a half weeks per vial
Limited Supply Bacteriostatic Water for Injection Bacteriostatic Water for Injection, USP is a sterile, nonpyrogenic preparation of water for injection containing 0.9% (9 mg/mL) or 1.1% (11 mg/mL) of benzyl alcohol added as a bacteriostatic preservative
Singh S, Allegretti JR, Siddique SM, Terdiman JP
not for human or veterinary use All Peptide Researches compounds are supplied strictly for in-vitro research use only